Literature DB >> 8139005

Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation.

D Spitkovsky1, P Steiner, J Lukas, E Lees, M Pagano, A Schulze, S Joswig, D Picard, M Tommasino, M Eilers.   

Abstract

To investigate how adenovirus E1A controls cell proliferation, we have fused E1A to the hormone-binding domain of the human estrogen receptor (ER) and introduced the E1A-ER chimeric gene together with an activated ras gene into primary rat embryo fibroblasts. Cell lines derived from this transfection proliferate in an estrogen-dependent manner. Estrogen-dependent activation of E1A-ER led to a rapid induction of both cyclin E and cyclin A gene expression. In contrast, levels of cyclin D1 were strongly reduced by activation of E1A-ER. Similar changes in cyclin gene expression were observed when primary human fibroblasts were infected with wild-type adenovirus and when adenovirus E1A was stably expressed in NIH 3T3 cells. Our findings suggest that activation of cyclin A and E, but not D1, gene expression by E1A precedes and may be responsible for E1A-dependent cell proliferation. In contrast, we found that quantitative disruption of complexes between the E2F transcription factor and the retinoblastoma protein is not required for E1A-dependent S-phase entry.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139005      PMCID: PMC236696     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  Association of cdk2 kinase with the transcription factor E2F during S phase.

Authors:  M Pagano; G Draetta; P Jansen-Dürr
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

3.  The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.

Authors:  A W Murray; M J Solomon; M W Kirschner
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

4.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

5.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

6.  Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.

Authors:  L H Tsai; E Harlow; M Meyerson
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

Review 7.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

Authors:  A Koff; F Cross; A Fisher; J Schumacher; K Leguellec; M Philippe; J M Roberts
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  The MYC protein activates transcription of the alpha-prothymosin gene.

Authors:  M Eilers; S Schirm; J M Bishop
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  26 in total

1.  Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.

Authors:  L Le Cam; J Polanowska; E Fabbrizio; M Olivier; A Philips; E Ng Eaton; M Classon; Y Geng; C Sardet
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

2.  Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.

Authors:  D Rinaudo; S Lamartina; G Roscilli; G Ciliberto; C Toniatti
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.

Authors:  A Sandmöller; H Meents; H H Arnold
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 4.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

5.  Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter.

Authors:  J Botz; K Zerfass-Thome; D Spitkovsky; H Delius; B Vogt; M Eilers; A Hatzigeorgiou; P Jansen-Dürr
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events.

Authors:  J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

7.  Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression.

Authors:  Kathleen F Richards; Anna Guastafierro; Masahiro Shuda; Tuna Toptan; Patrick S Moore; Yuan Chang
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

8.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107.

Authors:  K Zerfass; D Spitkovsky; A Schulze; S Joswig; B Henglein; P Jansen-Dürr
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.